Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,676 | 55,516 | 36,632 | 26,371 | 29,117 |
| Marketable Securities | 875,936 | 306,563 | 118,853 | 175,732 | 219,269 |
| TOTAL | $907,216 | $367,225 | $167,040 | $210,528 | $256,104 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,105 | 1,265 | 1,489 | 134 | 398 |
| TOTAL | $1,105 | $1,265 | $1,489 | $134 | $398 |
| Total Assets | $908,321 | $368,490 | $168,529 | $210,662 | $256,502 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,813 | 7,512 | 8,529 | 1,444 | 3,988 |
| TOTAL | $27,413 | $19,135 | $21,947 | $8,778 | $12,129 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 630 | 936 | 1,260 | 0 | 29 |
| TOTAL | $630 | $936 | $1,260 | $N/A | $29 |
| Total Liabilities | $28,043 | $20,071 | $23,207 | $8,778 | $12,158 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 112,248 | 100,488 | 78,419 | 78,363 | 74,133 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -487,907 | -377,944 | -292,049 | -223,182 | -168,192 |
| Other shareholders' equity | -788 | -184 | -897 | -549 | -54 |
| TOTAL | $880,278 | $348,419 | $145,322 | $201,884 | $244,344 |
| Total Liabilities And Equity | $908,321 | $368,490 | $168,529 | $210,662 | $256,502 |